Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Total Debt (2018 - 2026)

Exagen filings provide 9 years of Total Debt readings, the most recent being $22.9 million for Q1 2026.

  • On a quarterly basis, Total Debt rose 9.22% to $22.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $22.9 million, a 9.22% increase, with the full-year FY2025 number at $22.9 million, up 13.15% from a year prior.
  • Total Debt hit $22.9 million in Q1 2026 for Exagen, roughly flat from $22.9 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $29.3 million in Q1 2023 to a low of $19.4 million in Q2 2023.
  • Median Total Debt over the past 5 years was $22.9 million (2026), compared with a mean of $23.1 million.
  • Biggest five-year swings in Total Debt: crashed 33.43% in 2024 and later rose 13.45% in 2025.
  • Exagen's Total Debt stood at $29.0 million in 2022, then plummeted by 32.7% to $19.5 million in 2023, then increased by 3.85% to $20.2 million in 2024, then grew by 13.15% to $22.9 million in 2025, then dropped by 0.16% to $22.9 million in 2026.
  • The last three reported values for Total Debt were $22.9 million (Q1 2026), $22.9 million (Q4 2025), and $22.9 million (Q3 2025) per Business Quant data.